ARIELLA ROSENFELD: Open Payments
NPI 1225734221 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 45 payments from 13 companies in 2025. Trend: 2023 $284 · 2024 $279 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $167 |
| ABBVIE INC. | 9 | $141 |
| Amgen Inc. | 5 | $88 |
| Botanix SB Inc | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Arcutis Biotherapeutics, Inc. | 4 | $76 |
| GENZYME CORPORATION | 2 | $35 |
| ConvaTec Inc. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $17 |
Products named: SKYRIZI, NEMLUVIO, Otezla, SOFDRA, COSENTYX, Zoryve, DUPIXENT, INNOVAMATRIX AC.
Industry payments across NJ — which companies pay providers there.
